Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia.
Institute for Health Research, Kaiser Permanente Colorado and Ambulatory Care Services, Denver Health, Denver, Colorado.
Pediatr Neurol. 2017 Nov;76:72-78. doi: 10.1016/j.pediatrneurol.2017.08.005. Epub 2017 Aug 23.
The risk of febrile seizure is temporarily increased for a few days after the administration of certain vaccines in children aged six to 23 months. Our objective was to determine the febrile seizure risk following vaccination in children aged one to five months, when six different vaccines are typically administered.
We identified emergency department visits and inpatient admissions with International Classification of Diseases, Ninth Revision, febrile seizure codes among children enrolled in nine Vaccine Safety Datalink participating health care organizations from 2006 through 2011. Febrile seizures were confirmed by medical record abstraction. We used the self-controlled risk-interval method to compare the incidence of febrile seizure during postvaccination days 0 to 1 (risk interval) versus days 14 to 20 (control interval).
We identified 15 febrile seizure cases that occurred after 585,342 vaccination visits. The case patients were aged three to five months. The patients had received a median of four (range two to six) vaccines simultaneously. The incidence rate ratio of febrile seizure after vaccination was 23 (95% confidence interval 5.13 to 100.8), and the attributable risk was 3.92 (95% confidence interval 1.68 to 6.17) febrile seizure cases per 100,000 persons vaccinated.
Vaccination in children aged three to five months was associated with a large relative risk of febrile seizure on the day of and the day after vaccination, but the risk was small in absolute terms. Postvaccination febrile seizure should not be a concern for the vast majority of children receiving vaccines, but clinicians might take this risk into consideration when evaluating and treating children susceptible to seizures precipitated by fever.
在接种某些疫苗后,6 至 23 个月大的儿童会在几天内出现发热性惊厥的风险暂时增加。我们的目的是确定在接种疫苗后 1 至 5 个月大的儿童中,即通常接种六种不同疫苗时,发热性惊厥的风险。
我们从 2006 年至 2011 年期间,在参与疫苗安全数据链接的九个医疗保健组织中,确定了患有国际疾病分类,第九版发热性惊厥代码的急诊就诊和住院儿童。通过病历摘录来确认发热性惊厥。我们使用自我对照风险间隔法比较接种后 0 至 1 天(风险间隔)和 14 至 20 天(对照间隔)期间发热性惊厥的发生率。
我们在 585342 次疫苗接种就诊中发现了 15 例发热性惊厥病例。病例患者年龄为 3 至 5 个月。患者同时接受了中位数为 4 种(范围为 2 至 6 种)疫苗的接种。接种后发热性惊厥的发病率比值比为 23(95%置信区间 5.13 至 100.8),归因风险为每 100000 人接种 3.92(95%置信区间 1.68 至 6.17)例发热性惊厥。
在 3 至 5 个月大的儿童中接种疫苗与接种当天和次日发热性惊厥的相对风险较大有关,但从绝对风险来看,风险较小。接种后发热性惊厥不应引起大多数接受疫苗接种的儿童的关注,但临床医生在评估和治疗易受发热引起惊厥的儿童时可能会考虑这种风险。